Volatile organic compounds (VOCs) are organic chemical substances that volatilize easily in ambient air at normal temperature and pressure. VOCs in human expired gas have been reported to be useful in the diagnosis of various diseases, but measurement of VOCs in human expired gas is technically dif cult because the concentrations in expired gas are extremely low and almost the same as the concentrations in ambient air. Accurate VOC measurement usually requires a large system, and no VOC measuring systems suitable for clinical practice are available. We developed a compact, simple, double cold trap system that can measure the concentrations of VOCs originating in humans. Our system detects a limited number of VOCs with very high sensitivity at concentrations as low as 0.05 ppb. We evaluated the reproducibility of our system and measured VOCs in ambient air, puri ed air, and human expired gas from smokers, non-smokers, and patients. Errors of ±10% seem unavoidable in our system. Our veri cation experiment using human expired gas strongly suggests that the reproducibility and detection sensitivity of our system allow the detection of most VOCs in human expired gas.
Introduction
After Pauling et al. [1] reported in 1971 that human expired gas and urine contain many substances, high expectations have been placed on using volatile organic compounds (VOCs) in human expired gas as biomarkers for various diseases. Human expired gas contains more than 200 VOCs [2] , and studies have reported that VOCs in human expired gas are useful for diagnosing lung cancer [3] , pulmonary tuberculosis [4] , and breast cancer [5] . Also, measurement of expired gas is less invasive than blood sampling. However, measurement of VOCs in expired gas is technically dif cult because the concentrations of VOCs in human expired gas are less than 1 ppb, almost the same as the concentrations in ambient air [6, 7] . The VOCs in human expired gas are greatly affected by the VOCs in ambient air. Therefore, to detect only the VOCs that originate from a human subject, the subject needs to breathe extremely pure air. Very large equipment is needed to completely remove the VOCs in ambient air. Moreover, the expired gas has to be concentrated in order to accurately measure the concentrations of VOCs, which also requires a large system. Currently, no VOC measuring systems that are suitable for clinical practice are available.
Some studies used a cold trap method to concentrate human expired gas [8] . Use of a single cold trap and puri ed air allows accurate measurement of VOCs, but the large and complicated system is unsuitable for clinical practice. Also, not only expired gas but also ambient air are included in the measurement. Another technology eNose ® uses a gas sensor array to analyze expired gas. Although eNose is easy to use and is available commercially [9] , many negative reports on its medical applicability have been published because VOC concentrations cannot be measured speci cally or quantitatively [10, 11] . We developed a new expired gas measurement system that uses a double cold trap method to measure only the VOCs of human origin. Our system is simple and has high sensitivity, but can only detect a limited number of VOCs. We evaluated the reproducibility of the results obtained using our system and measured VOCs in ambient air, puri ed air, and human expired gas from smokers, non-smokers, and patients.
Materials and Methods
The protocol of the study was approved by the Tokai University Ethics Committee, and the study was performed according to the principles of the Declaration of Helsinki. We also used methods similar to those of some previous studies [2] . A double cold trap method allows simpli cation of the system while retaining the ability to distinguish VOCs in ambient air from VOCs emitted from humans.
Our method consists of four steps: air puri cation, expired gas collection, expired gas concentration, and gas chromatography analysis. Figure 1 shows the processes in our system. (a) VOCs in ambient air are trapped in a cold puri cation tube. Puried ambient air is collected in a gas sampling bag. (b) The subject inspires puri ed air from the gas sampling bag, then expires into another sampling bag. (c) VOCs in the expired gas are trapped in a concentration tube cooled to −80 C. The concentration tube has the same mechanism as the puri cation tube, trapping and passing the same VOCs. (d) The trapped VOCs in the concentration tube are released by heating at 80 C. (e) Expired gas in the concentration tube is sampled with a syringe and analyzed with a gas chromatograph. Figure 2 shows how our system eliminates the VOCs in atmospheric air and detects only the VOCs originating in humans. This example assumes ve kinds of VOCs (A, B, C, D, and E) in ambient air and human expired gas. A, B, and C are VOCs that exist in ambient air. B, D, and E are VOCs that exist in human expired gas. A, B and D are VOCs that are trapped by the cold trap. C and E are VOCs that are not trapped by the cold trap.
(1) Assume that room air contains three VOCs; A, B 1 , and C. (2) The puri cation tube traps A and B 1 . (3) C passes through the sampling unit and is inspired by the human subject along with the puri ed air. (4) Assume that three VOCs; B 2 , D, and E, are produced by the human subject. (5) B 2 , D, E, and C are expired into the sampling unit. (6) C and E are not trapped by the concentration tube, and are discharged from the system. We used the same cold trap for puri cation and concentration. That is why we call our system double cold trap. In our double cold trap system, VOCs that exist in ambient air either are removed by the puri cation tube or pass through the system without being analyzed. Thus, our system only measures VOCs that originate in human subjects. Some VOCs from humans are not trapped by the concentration tube; and therefore cannot be measured by our system. Figures 3 and 4 show the air puri cation device. The device has a control unit with an air pump, a moisture absorption device for removing moisture in ambient air, a puri cation tube for removing VOCs in ambient air, and a cooling tank.
Air puri cation
Room air from the air pump (P22D02, Okenseiko Co., Ltd., Tokyo, Japan) passes through a silicon connecting tube into a moisture absorption device lled with activated carbon. The ow rate of the pump is set at 500 mL/min. Dry air ows into the puri cation tube inside the cooling tank. The puri cation tube is a stainless pipe (inside diameter of 4.2 mm, length of 1000 mm) lled with 13 g of stainless steel wool. The cooling tank is a stainless steel box (300 mm in width, 100 mm in depth, and 150 mm in height) lled with 2 kg of silicone oil and 4 kg of crushed dry ice. The puri cation tube in the cooling tank is cooled to approximately −80 C. The VOCs in the puri cation tube are cooled, condensed and trapped on the surface of the stainless steel wool. The puri ed air ows out of the tube into a polyvinyl uoride lm bag (Tedlar Bag ® , DuPont, Wilmington, USA). Before the air puri cation process, the puri cation tube is heated at 80 C for 30 min in an electric drying oven (DOV-450, As One Corporation, Osaka, Japan) to remove VOCs from the tube. Figure 5 shows the expired gas collection device. The sampling unit has four solenoid valves (Red Hat II, J210G035MB, J210G095MB, ASCO Japan Co., Ltd., Hyogo, Japan). Attached to the sampling unit are a mask (King Mask ® , King Systems, Noblesville, USA) with a breathing circuit lter (BB50T Breathing Circuit Filter, Pall Corporation, New York, USA) to prevent infection, and three polyvinyl uoride lm bags. A 5 L bag and a 10 L bag hold the puri ed air and another 5 L bag collects the expired gas. The expired gas is collected in three modes, which are controlled by solenoid valves. Mode 1: The subject inspires room air and expires into ambient air. After the subject s breathing stabilizes, collection is switched to mode 2. Mode 2: The subject inspires puri ed air from the 10 L bag and expires into ambient air. This ushes the VOCs in previously inhaled ambient air from the subject s lungs. When the 10 L bag is empty, collection is switched to mode 3. Mode 3: The subject inspires puri ed air from one 5 L bag and expires into the other 5 L bag.
Expired gas collection

Expired gas concentration
Expired gas was analyzed four hours after sampling to eliminate the in uence of humidity in the expired gas [12] . The expired gas concentration process uses the same principle as the air puri cation process. A second pump in the control unit aspirates the expired gas in the 5 L bag through the concentration tube. The ow rate of the pump is set at 500 mL/min. The concentration tube has an inside diameter of 4.2 mm and a length of 100 mm, and is lled with 1.3 g of stainless steel wool. The concentration tube has a similar structure to the puri cation tube (Fig. 4) . However, the puri cation tube is 10 times longer because ambient air presumably contains more impurities than the expired gas. The concentration tube is cooled to approximately −80 C in the cooling tank, and the VOCs are cooled, condensed, and trapped on the surface of the stainless steel wool in the concentration tube. The valves at both ends of the concentration tube are closed to sample the expired gas. Before the concentration process, the concentration tube is heated to 80 C for 30 min in the same electrical drying oven to remove VOCs, as in the puri cation process. In most of the previously reported systems, the subjects inspired puri ed air. However, it is technically dif cult to render air completely free of VOCs. Even if the inspired air is highly puri ed, it is not possible to remove the impurities that have already entered the lungs via the ambient air and are expired from the lungs. This problem is solved by applying the cold trap method to both the air puri cation process and the expired gas concentration process in the same manner. VOCs that are not trapped in the air puri cation process are also not trapped in the concentration tube. Therefore, these VOCs are not detected by gas chromatographic analysis. VOCs which are trapped in the expired gas concentration process are also trapped in the air puri cation process. Therefore, the only VOCs detected by our system are those originating in the human body.
Gas chromatographic analysis
The VOCs in the expired gas are released from the stainless steel wool in the concentration tube by heating to 80 C for 30 min. After heating, a syringe is connected to an outlet of the concentration tube and 1 mL of concentrated expired gas is sampled by releasing the valve of the concentration tube. The VOCs in the expired gas are analyzed using a versatile standard capillary and packed gas chromatograph (GC-2014, Shimadzu Corporation, Kyoto, Japan) equipped with a ame ionization detector (FID-2014, Shimadzu Corporation, Kyoto, Japan). An open-tubular, wide-bore and no-polarity column made of Pyrex glass [G-100, Chemicals Evaluation and Research Institute (CERI), Tokyo, Japan] is used to separate the VOCs. The column has an inside diameter of 1.2 mm, an outside diameter of 1.6 mm, and a length of 40 m. The inner surface of the column has a 2-μm coating of methyl silicone in liquid phase. Table 1 shows the optimized operating conditions. The gas chromatographic pro le acquired is analyzed using commercial software (GCsolution ver. 2, Shimadzu Corporation, Kyoto, Japan) and converted to peak areas that are proportional to the concentrations of the VOCs detected. Peaks with the same retention time are considered to be the same VOC.
Target VOCs and standard gas
To simplify our system, ten target VOCs were selected. To determine target VOCs for our system, the expired gas of healthy volunteers was analyzed by gas chromatography / mass spectrometry (GC/MS, HP6890 and HP5973, Agilent Technologies, Santa (114) Clara, USA) and ten target VOCs suitable for the diagnosis of pulmonary diseases were selected based on past studies [2] [3] [4] [5] , as shown in Table 2 . Standard reference gas containing the target VOCs was prepared (Japan Fine Products Corporation, Kanagawa, Japan). Standard gas A had a concentration of 100 ppb and standard gas B a concentration of 10 ppb. The procedures of air puri cation and expired gas collection were omitted in the experiment using standard gas. Standard gas was injected directly into the sampling bag. Thereafter, the standard gases were processed in the same manner as human expired gas samples.
Results and Discussion
Reproducibility
To assess the reproducibility of our system, the VOC concentrations in 5 L of standard gases A and B were measured. The measurement was repeated 10 times. Table 2 shows the results. The average standard deviation was 10.11 ppb for gas A (100 ppb) and 1.91 ppb for gas B (10 ppb). Errors of ±10% seem to be unavoidable in our system. We suspect that these variations are due to the large number of manual operations. We measured the system linearity using standard gases of 50 ppb and 200 ppb, which were similarly prepared as the standard gases A and B (Japan Fine Products Corporation, Kanagawa, Japan). Figure 6 shows the result of veri cation of linearity, demonstrating the relationship between VOC concentration and chromatographic peak area, where the peak area for VOC concentration of 10 ppb is normalized to 1. The correlation coef cient between the peak area and VOC concentration is 0.992. These results con rm linearity of the system for the expected measurement range of VOC concentrations in human expired gas.
VOC concentration can be obtained from the peak area using the calibration curve shown in Figure 6 . The minimum gas chromatographic detectable peak area is 1000. The minimum sensitivity of detection of each VOC was obtained using the calibration curve and the minimum detectable peak area ( Table 2) . The results show that our system can detect VOCs at concentrations greater than 0.05 ppb.
Measurement of VOCs in ambient air
To evaluate the VOC removal capacity of the puri cation tube, we measured the concentrations of VOCs in ambient air using our system. Table 3 shows the results ( ambient air ) obtained in the present study and those from previous studies [13] [14] [15] [16] [17] [18] . Our results are consistent with those of other studies, but show slightly low VOC concentrations. The discrepancy is probably due to the place of sampling. Previous studies collected atmospheric air mainly along roads or in homes, while we collected ambient air in the laboratory.
Measurement of VOCs in puri ed air
The VOC removal performance of the puri cation tube was evaluated using standard gas B. The measurement was repeated 4 times. Table 4 shows the concentrations of VOCs after puri cation. Six of the ten VOCs were not detected. Of the four VOCs that were detected, most of the concentrations were close to the minimum detectable levels. We consider that the concentrations of VOCs in the puri ed air are suf ciently low compared with the concentrations of VOCs in human expired gas, and hence are not likely to affect the analysis of human expired gas.
Measurement of VOCs in human expired gas
Expired gas was sampled from 33 healthy volunteers. None of the healthy volunteers had a history or symptoms of respiratory disease. Most of the volunteers were medical professionals in the facility. To reduce the in uence of eating and drinking, expired gas was collected after the subjects gargled with puri ed water. All expired gas samples were collected during breathing at rest. Table 5 shows the results obtained from our healthy volunteers and results from other studies [19] . Our results show lower VOC concentrations. A probable explanation is that our system detects only VOCs originating from humans, whereas results from previous studies also included VOCs from ambient air. Moreover, VOC concentration in expired gas depends on the surrounding environment. Environmental differences may also affect VOC concentration measurements. High humidity also affects VOC measurement. This effect can be reduced if the subject inspires air with very low humidity or if analysis is performed more than four hours after sampling.
Comparison of expired gas of smokers and non-smokers
The concentrations of VOCs in expired gas were compared between a smoker group (including current and past smokers) and a non-smoker group. Both groups were drawn from 33 healthy volunteers (12 smokers and 21 non-smokers). The Mann-Whitney U-test was used to evaluate statistically signi cant differences between the smoker and non-smoker groups. A p-value less than 0.05 was considered statistically signi cant. The results are shown in Table 6 . The concentration of benzene was signi cantly higher in the smoker group. Table 5 VOCs in human expired gas (mean ± standard deviation, in ppb). (116)
Initial assessment of patient s expired gas
To evaluate the clinical usefulness of our system, the expired gas of one patient with sleep apnea syndrome (SAS) and one patient with lung cancer was analyzed. To ensure safety, expired gas samples were collected under observation by a medical doctor. The results are shown in Table 7 . The concentration of isoprene in the SAS patient was approximately 3 times (healthy 32.8 vs SAS 90.7) higher than in healthy volunteers, and the concentration of xylene in the lung cancer patient was approximately 2 times (healthy 0.19 vs lung cancer 0.44) that of healthy volunteers. The analysis of reproducibility showed that the largest error of our system was 20%. Although we only have data of these two clinical cases, the results suggest that the difference between the patients and healthy persons is suf ciently larger than the error of our system.
Conclusion
Our system is easy to use, inexpensive, and can measure the concentrations of a limited number of VOCs in human expired gas with high sensitivity. A unique feature of our system is that only VOCs originating in humans are measured, thus avoiding the effect of VOCs in ambient air. By using the double cold trap method, high sensitivity of detection of a limited number of VOCs was obtained by our small-scale system. The analysis of human expired gas using our system still requires gas chromatography. A smaller and more practical analytical system may be developed by further limiting VOC. The results of reproducibility analysis and initial clinical experiments suggest that our system has sufcient capability to diagnose respiratory diseases. The reproducibility of our system would be improved by introducing automated processing. Although we investigated only a small number of patients, we found candidate substances in human expired gas as biomarkers for SAS and lung cancer. This nding suggests that our system has the potential for clinical use. The usefulness of our system should be con rmed by studying a large number of cases. Our double trap technique can be applied to methods other than the cold trap method. It takes a long time to purify air by the cold trap method due to the need for pre-cooling of the puri cation tube. We shall examine other methods such as solid absorbent that does not require cooling time. (118)
